| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.849 | 0.002 | 0.849 | Diuretic | 0.601 0.005 DBMET00490 0.468 0.009 DBMET00492 0.849 0.002 DBMET00530 0.408 0.013 DBMET03004 0.468 0.009 DBMET03005 | ||
| 0.751 | 0.005 | 0.751 | Cholesterol antagonist | 0.705 0.008 DBMET00490 0.619 0.016 DBMET00492 0.751 0.005 DBMET00530 0.678 0.01 DBMET03004 0.619 0.016 DBMET03005 | ||
| 0.744 | 0.002 | 0.781 | Estrogen agonist | 0.744 0.002 DBMET00490 0.781 0.002 DBMET00492 0.744 0.002 DBMET00530 0.699 0.003 DBMET03004 0.781 0.002 DBMET03005 | DBMET03005 | |
| 0.682 | 0.002 | 0.774 | Aromatase inhibitor | 0.773 0.002 DBMET00490 0.635 0.002 DBMET00492 0.682 0.002 DBMET00530 0.774 0.002 DBMET03004 0.635 0.002 DBMET03005 | DBMET03004 | |
| 0.64 | 0.002 | 0.64 | Cholecystokinin B agonist | 0.64 0.002 DBMET00530 | ||
| 0.618 | 0.002 | 0.618 | Cholecystokinin agonist | 0.618 0.002 DBMET00530 | ||
| 0.617 | 0.049 | 0.699 | Antiinflammatory | 0.605 0.052 DBMET00490 0.699 0.031 DBMET00492 0.617 0.049 DBMET00530 0.6 0.053 DBMET03004 0.699 0.031 DBMET03005 | DBMET03005 | |
| 0.531 | 0.04 | 0.782 | Transcription factor NF kappa B inhibitor | 0.725 0.018 DBMET00490 0.78 0.014 DBMET00492 0.531 0.04 DBMET00530 0.782 0.014 DBMET03004 0.78 0.014 DBMET03005 | DBMET03004 | |
| 0.476 | 0.004 | 0.539 | Lipocortins synthesis antagonist | 0.539 0.003 DBMET00490 0.527 0.003 DBMET00492 0.476 0.004 DBMET00530 0.525 0.003 DBMET03004 0.527 0.003 DBMET03005 | DBMET00490 | |
| 0.473 | 0.003 | 0.545 | Estrogen receptor beta agonist | 0.518 0.003 DBMET00490 0.545 0.002 DBMET00492 0.473 0.003 DBMET00530 0.386 0.003 DBMET03004 0.545 0.002 DBMET03005 | DBMET03005 | |
| 0.489 | 0.034 | 0.944 | Aldehyde oxidase inhibitor | 0.942 0.003 DBMET00490 0.944 0.003 DBMET00492 0.489 0.034 DBMET00530 0.925 0.003 DBMET03004 0.944 0.003 DBMET03005 | DBMET03005 | |
| 0.449 | 0.008 | 0.497 | Sodium/bile acid cotransporter inhibitor | 0.478 0.005 DBMET00490 0.497 0.004 DBMET00492 0.449 0.008 DBMET00530 0.491 0.004 DBMET03004 0.497 0.004 DBMET03005 | DBMET03005 | |
| 0.443 | 0.002 | 0.443 | Cholecystokinin A agonist | 0.443 0.002 DBMET00530 | ||
| 0.432 | 0.002 | 0.678 | Androgen agonist | 0.528 0.002 DBMET00490 0.565 0.002 DBMET00492 0.432 0.002 DBMET00530 0.678 0.001 DBMET03004 0.565 0.002 DBMET03005 | DBMET03004 | |
| 0.416 | 0.001 | 0.553 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.553 0.001 DBMET00490 0.369 0.002 DBMET00492 0.416 0.001 DBMET00530 0.393 0.001 DBMET03004 0.369 0.002 DBMET03005 | DBMET00490 | |
| 0.416 | 0.004 | 0.416 | Cholesterol synthesis inhibitor | 0.393 0.005 DBMET00490 0.388 0.005 DBMET00492 0.416 0.004 DBMET00530 0.387 0.005 DBMET03004 0.388 0.005 DBMET03005 | ||
| 0.458 | 0.047 | 0.458 | Antiobesity | 0.262 0.146 DBMET00490 0.274 0.136 DBMET00492 0.458 0.047 DBMET00530 0.274 0.136 DBMET03005 | ||
| 0.423 | 0.018 | 0.423 | Angiogenesis stimulant | 0.223 0.083 DBMET00490 0.262 0.065 DBMET00492 0.423 0.018 DBMET00530 0.294 0.051 DBMET03004 0.262 0.065 DBMET03005 | ||
| 0.424 | 0.021 | 0.524 | Interleukin 2 agonist | 0.524 0.005 DBMET00490 0.349 0.046 DBMET00492 0.424 0.021 DBMET00530 0.435 0.018 DBMET03004 0.349 0.046 DBMET03005 | DBMET00490 | |
| 0.396 | 0.001 | 0.429 | Anabolic | 0.35 0.001 DBMET00490 0.429 0.001 DBMET00492 0.396 0.001 DBMET00530 0.323 0.001 DBMET03004 0.429 0.001 DBMET03005 | DBMET03005 | |
| 0.379 | 0.003 | 0.878 | Estradiol 17 beta-dehydrogenase inhibitor | 0.878 0.001 DBMET00490 0.65 0.002 DBMET00492 0.379 0.003 DBMET00530 0.694 0.001 DBMET03004 0.65 0.002 DBMET03005 | DBMET00490 | |
| 0.408 | 0.034 | 0.48 | Antioxidant | 0.388 0.037 DBMET00490 0.48 0.022 DBMET00492 0.408 0.034 DBMET00530 0.447 0.027 DBMET03004 0.48 0.022 DBMET03005 | DBMET03005 | |
| 0.4 | 0.03 | 0.718 | Hypoxia-inducible factor 1 alpha inhibitor | 0.695 0.004 DBMET00490 0.718 0.004 DBMET00492 0.4 0.03 DBMET00530 0.679 0.005 DBMET03004 0.718 0.004 DBMET03005 | DBMET03005 | |
| 0.453 | 0.09 | 0.77 | Apoptosis agonist | 0.65 0.039 DBMET00490 0.735 0.025 DBMET00492 0.453 0.09 DBMET00530 0.77 0.02 DBMET03004 0.735 0.025 DBMET03005 | DBMET03004 | |
| 0.409 | 0.051 | 0.409 | Angiogenesis inhibitor | 0.202 0.167 DBMET00492 0.409 0.051 DBMET00530 0.357 0.068 DBMET03004 0.202 0.167 DBMET03005 | ||
| 0.36 | 0.002 | 0.36 | Glycine receptor antagonist | 0.233 0.003 DBMET00490 0.187 0.004 DBMET00492 0.36 0.002 DBMET00530 0.216 0.003 DBMET03004 0.187 0.004 DBMET03005 | ||
| 0.372 | 0.015 | 0.372 | Platelet adhesion inhibitor | 0.175 0.085 DBMET00490 0.292 0.036 DBMET00492 0.372 0.015 DBMET00530 0.199 0.072 DBMET03004 0.292 0.036 DBMET03005 | ||
| 0.399 | 0.049 | 0.399 | Antithrombotic | 0.219 0.155 DBMET00490 0.262 0.117 DBMET00492 0.399 0.049 DBMET00530 0.262 0.117 DBMET03004 0.262 0.117 DBMET03005 | ||
| 0.354 | 0.014 | 0.491 | Phospholipase C inhibitor | 0.348 0.014 DBMET00490 0.491 0.006 DBMET00492 0.354 0.014 DBMET00530 0.413 0.01 DBMET03004 0.491 0.006 DBMET03005 | DBMET03005 | |
| 0.341 | 0.012 | 0.341 | Hemostatic | 0.341 0.012 DBMET00530 | ||
| 0.33 | 0.005 | 0.699 | Estrogen antagonist | 0.677 0.003 DBMET00490 0.699 0.003 DBMET00492 0.33 0.005 DBMET00530 0.505 0.004 DBMET03004 0.699 0.003 DBMET03005 | DBMET03005 | |
| 0.302 | 0.007 | 0.575 | Androgen antagonist | 0.575 0.003 DBMET00490 0.435 0.004 DBMET00492 0.302 0.007 DBMET00530 0.429 0.004 DBMET03004 0.435 0.004 DBMET03005 | DBMET00490 | |
| 0.31 | 0.016 | 0.718 | NOS3 expression enhancer | 0.5 0.005 DBMET00490 0.718 0.003 DBMET00492 0.31 0.016 DBMET00530 0.461 0.006 DBMET03004 0.718 0.003 DBMET03005 | DBMET03005 | |
| 0.308 | 0.018 | 0.308 | Protein-tyrosine phosphatase inhibitor | 0.13 0.102 DBMET00490 0.125 0.107 DBMET00492 0.308 0.018 DBMET00530 0.125 0.107 DBMET03005 | ||
| 0.353 | 0.064 | 0.378 | Immunostimulant | 0.294 0.08 DBMET00490 0.378 0.056 DBMET00492 0.353 0.064 DBMET00530 0.318 0.074 DBMET03004 0.378 0.056 DBMET03005 | DBMET03005 | |
| 0.286 | 0.001 | 0.286 | Estrone sulfatase inhibitor | 0.227 0.002 DBMET00490 0.185 0.002 DBMET00492 0.286 0.001 DBMET00530 0.189 0.002 DBMET03004 0.185 0.002 DBMET03005 | ||
| 0.281 | 0.004 | 0.281 | Cholecystokinin A antagonist | 0.281 0.004 DBMET00530 | ||
| 0.305 | 0.028 | 0.305 | Anticoagulant | 0.305 0.028 DBMET00530 | ||
| 0.28 | 0.004 | 0.542 | Estrogen receptor alpha agonist | 0.49 0.002 DBMET00490 0.542 0.002 DBMET00492 0.28 0.004 DBMET00530 0.364 0.003 DBMET03004 0.542 0.002 DBMET03005 | DBMET03005 | |
| 0.301 | 0.029 | 0.35 | Hepatoprotectant | 0.296 0.031 DBMET00490 0.35 0.019 DBMET00492 0.301 0.029 DBMET00530 0.335 0.021 DBMET03004 0.35 0.019 DBMET03005 | DBMET03005 | |
| 0.271 | 0.002 | 0.772 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.772 0.001 DBMET00490 0.435 0.001 DBMET00492 0.271 0.002 DBMET00530 0.468 0.001 DBMET03004 0.435 0.001 DBMET03005 | DBMET00490 | |
| 0.272 | 0.004 | 0.272 | Multidrug resistance-associated protein 1 inhibitor | 0.131 0.038 DBMET00490 0.111 0.06 DBMET00492 0.272 0.004 DBMET00530 0.097 0.084 DBMET03004 0.111 0.06 DBMET03005 | ||
| 0.306 | 0.039 | 0.526 | Nitric oxide antagonist | 0.427 0.022 DBMET00490 0.526 0.014 DBMET00492 0.306 0.039 DBMET00530 0.459 0.019 DBMET03004 0.526 0.014 DBMET03005 | DBMET03005 | |
| 0.29 | 0.034 | 0.29 | RNA-directed DNA polymerase inhibitor | 0.232 0.062 DBMET00490 0.2 0.099 DBMET00492 0.29 0.034 DBMET00530 0.208 0.088 DBMET03004 0.2 0.099 DBMET03005 | ||
| 0.252 | 0.004 | 0.252 | CDC25A inhibitor | 0.18 0.009 DBMET00490 0.087 0.036 DBMET00492 0.252 0.004 DBMET00530 0.137 0.015 DBMET03004 0.087 0.036 DBMET03005 | ||
| 0.249 | 0.005 | 0.249 | NMDA 2B receptor antagonist | 0.049 0.044 DBMET00492 0.249 0.005 DBMET00530 0.049 0.044 DBMET03005 | ||
| 0.333 | 0.096 | 0.517 | Immunosuppressant | 0.403 0.062 DBMET00490 0.517 0.028 DBMET00492 0.333 0.096 DBMET00530 0.459 0.044 DBMET03004 0.517 0.028 DBMET03005 | DBMET03005 | |
| 0.239 | 0.005 | 0.239 | Carbonic anhydrase V inhibitor | 0.069 0.043 DBMET00490 0.239 0.005 DBMET00530 | ||
| 0.237 | 0.006 | 0.811 | Estrogen receptor alpha antagonist | 0.801 0.002 DBMET00490 0.811 0.002 DBMET00492 0.237 0.006 DBMET00530 0.671 0.003 DBMET03004 0.811 0.002 DBMET03005 | DBMET03005 | |
| 0.237 | 0.009 | 0.279 | Arachidonic acid antagonist | 0.274 0.003 DBMET00490 0.274 0.003 DBMET00492 0.237 0.009 DBMET00530 0.279 0.003 DBMET03004 0.274 0.003 DBMET03005 | DBMET03004 | |
| 0.226 | 0.004 | 0.226 | Cholecystokinin antagonist | 0.226 0.004 DBMET00530 | ||
| 0.222 | 0.004 | 0.222 | Cholecystokinin B antagonist | 0.222 0.004 DBMET00530 | ||
| 0.223 | 0.008 | 0.545 | Estrogen receptor beta antagonist | 0.535 0.004 DBMET00490 0.545 0.003 DBMET00492 0.223 0.008 DBMET00530 0.376 0.004 DBMET03004 0.545 0.003 DBMET03005 | DBMET03005 | |
| 0.216 | 0.004 | 0.395 | 5-Alpha-reductase inhibitor | 0.395 0.002 DBMET00490 0.314 0.003 DBMET00492 0.216 0.004 DBMET00530 0.313 0.003 DBMET03004 0.314 0.003 DBMET03005 | DBMET00490 | |
| 0.212 | 0.003 | 0.306 | RNA-directed RNA polymerase stimulant | 0.306 0.002 DBMET00490 0.265 0.002 DBMET00492 0.212 0.003 DBMET00530 0.207 0.003 DBMET03004 0.265 0.002 DBMET03005 | DBMET00490 | |
| 0.211 | 0.026 | 0.211 | Protein-tyrosine phosphatase 1B inhibitor | 0.116 0.066 DBMET00490 0.123 0.061 DBMET00492 0.211 0.026 DBMET00530 0.097 0.082 DBMET03004 0.123 0.061 DBMET03005 | ||
| 0.196 | 0.012 | 0.297 | Pregnane X receptor agonist | 0.249 0.005 DBMET00490 0.297 0.004 DBMET00492 0.196 0.012 DBMET00530 0.245 0.005 DBMET03004 0.297 0.004 DBMET03005 | DBMET03005 | |
| 0.194 | 0.017 | 0.253 | Adenylate cyclase stimulant | 0.219 0.007 DBMET00490 0.243 0.004 DBMET00492 0.194 0.017 DBMET00530 0.253 0.004 DBMET03004 0.243 0.004 DBMET03005 | DBMET03004 | |
| 0.182 | 0.006 | 0.182 | Carbonic anhydrase VA inhibitor | 0.079 0.037 DBMET00490 0.182 0.006 DBMET00530 | ||
| 0.199 | 0.042 | 0.321 | Lipid peroxidase inhibitor | 0.284 0.021 DBMET00490 0.306 0.018 DBMET00492 0.199 0.042 DBMET00530 0.321 0.016 DBMET03004 0.306 0.018 DBMET03005 | DBMET03004 | |
| 0.157 | 0.003 | 0.692 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.692 0.001 DBMET00490 0.409 0.002 DBMET00492 0.157 0.003 DBMET00530 0.5 0.002 DBMET03004 0.409 0.002 DBMET03005 | DBMET00490 | |
| 0.17 | 0.017 | 0.211 | Carbonic anhydrase VI inhibitor | 0.211 0.012 DBMET00490 0.106 0.036 DBMET00492 0.17 0.017 DBMET00530 0.109 0.034 DBMET03004 0.106 0.036 DBMET03005 | DBMET00490 | |
| 0.189 | 0.039 | 0.355 | Bone formation stimulant | 0.355 0.012 DBMET00490 0.26 0.023 DBMET00492 0.189 0.039 DBMET00530 0.218 0.031 DBMET03004 0.26 0.023 DBMET03005 | DBMET00490 | |
| 0.213 | 0.064 | 0.573 | Neurotrophic factor enhancer | 0.573 0.003 DBMET00490 0.485 0.004 DBMET00492 0.213 0.064 DBMET00530 0.49 0.004 DBMET03004 0.485 0.004 DBMET03005 | DBMET00490 | |
| 0.159 | 0.014 | 0.159 | Carbonic anhydrase inhibitor | 0.159 0.014 DBMET00530 | ||
| 0.147 | 0.006 | 0.15 | Na+ K+ transporting ATPase inhibitor | 0.145 0.007 DBMET00490 0.149 0.006 DBMET00492 0.147 0.006 DBMET00530 0.15 0.006 DBMET03004 0.149 0.006 DBMET03005 | DBMET03004 | |
| 0.146 | 0.008 | 0.239 | Bile acid receptor antagonist | 0.158 0.006 DBMET00490 0.239 0.004 DBMET00492 0.146 0.008 DBMET00530 0.179 0.005 DBMET03004 0.239 0.004 DBMET03005 | DBMET03005 | |
| 0.142 | 0.004 | 0.414 | 5-Alpha-reductase 1 inhibitor | 0.414 0.002 DBMET00490 0.183 0.003 DBMET00492 0.142 0.004 DBMET00530 0.208 0.003 DBMET03004 0.183 0.003 DBMET03005 | DBMET00490 | |
| 0.142 | 0.005 | 0.305 | Aldosterone antagonist | 0.305 0.003 DBMET00490 0.221 0.004 DBMET00492 0.142 0.005 DBMET00530 0.197 0.004 DBMET03004 0.221 0.004 DBMET03005 | DBMET00490 | |
| 0.281 | 0.15 | 0.281 | Antibacterial | 0.276 0.154 DBMET00492 0.281 0.15 DBMET00530 0.257 0.171 DBMET03004 0.276 0.154 DBMET03005 | ||
| 0.164 | 0.039 | 0.305 | Farnesoid X receptor antagonist | 0.266 0.009 DBMET00490 0.305 0.005 DBMET00492 0.164 0.039 DBMET00530 0.277 0.008 DBMET03004 0.305 0.005 DBMET03005 | DBMET03005 | |
| 0.14 | 0.015 | 0.14 | HIV-1 integrase (3'-Processing) inhibitor | 0.14 0.015 DBMET00530 | ||
| 0.188 | 0.068 | 0.188 | Dual specificity phosphatase 3 inhibitor | 0.188 0.068 DBMET00530 | ||
| 0.184 | 0.064 | 0.184 | Dual specificity phosphatase inhibitor | 0.184 0.064 DBMET00530 | ||
| 0.268 | 0.151 | 0.415 | 15-Lipoxygenase inhibitor | 0.415 0.068 DBMET00490 0.334 0.109 DBMET00492 0.268 0.151 DBMET00530 0.334 0.109 DBMET03005 | DBMET00490 | |
| 0.139 | 0.023 | 0.139 | Triose-phosphate isomerase inhibitor | 0.139 0.023 DBMET00530 | ||
| 0.124 | 0.016 | 0.124 | HIV-1 integrase (Strand Transfer) inhibitor | 0.072 0.035 DBMET00492 0.124 0.016 DBMET00530 0.072 0.035 DBMET03005 | ||
| 0.105 | 0.003 | 0.155 | Glucose-6-phosphate dehydrogenase inhibitor | 0.155 0.002 DBMET00490 0.081 0.004 DBMET00492 0.105 0.003 DBMET00530 0.108 0.003 DBMET03004 0.081 0.004 DBMET03005 | DBMET00490 | |
| 0.105 | 0.005 | 0.159 | Glucocorticoid antagonist | 0.159 0.004 DBMET00490 0.122 0.004 DBMET00492 0.105 0.005 DBMET00530 0.112 0.004 DBMET03004 0.122 0.004 DBMET03005 | DBMET00490 | |
| 0.207 | 0.11 | 0.207 | Superoxide dismutase inhibitor | 0.178 0.144 DBMET00490 0.207 0.11 DBMET00530 | ||
| 0.13 | 0.034 | 0.13 | Acetylcholine release stimulant | 0.13 0.034 DBMET00530 | ||
| 0.145 | 0.049 | 0.321 | Alkylator | 0.192 0.029 DBMET00490 0.321 0.011 DBMET00492 0.145 0.049 DBMET00530 0.229 0.019 DBMET03004 0.321 0.011 DBMET03005 | DBMET03005 | |
| 0.098 | 0.005 | 0.109 | Lipocortins synthesis agonist | 0.109 0.004 DBMET00490 0.106 0.004 DBMET00492 0.098 0.005 DBMET00530 0.106 0.004 DBMET03004 0.106 0.004 DBMET03005 | DBMET00490 | |
| 0.089 | 0.005 | 0.345 | 5-Alpha-reductase 2 inhibitor | 0.345 0.002 DBMET00490 0.187 0.003 DBMET00492 0.089 0.005 DBMET00530 0.21 0.003 DBMET03004 0.187 0.003 DBMET03005 | DBMET00490 | |
| 0.09 | 0.009 | 0.172 | Mineralocorticoid receptor antagonist | 0.172 0.004 DBMET00490 0.117 0.006 DBMET00492 0.09 0.009 DBMET00530 0.104 0.007 DBMET03004 0.117 0.006 DBMET03005 | DBMET00490 | |
| 0.106 | 0.029 | 0.106 | NMDA 2 receptor antagonist | 0.08 0.043 DBMET00490 0.075 0.047 DBMET00492 0.106 0.029 DBMET00530 0.068 0.053 DBMET03004 0.075 0.047 DBMET03005 | ||
| 0.127 | 0.053 | 0.261 | Microtubule formation inhibitor | 0.239 0.011 DBMET00490 0.255 0.007 DBMET00492 0.127 0.053 DBMET00530 0.261 0.006 DBMET03004 0.255 0.007 DBMET03005 | DBMET03004 | |
| 0.09 | 0.017 | 0.317 | Alpha tubulin antagonist | 0.225 0.005 DBMET00490 0.317 0.004 DBMET00492 0.09 0.017 DBMET00530 0.187 0.007 DBMET03004 0.317 0.004 DBMET03005 | DBMET03005 | |
| 0.082 | 0.014 | 0.106 | Heme oxygenase stimulant | 0.106 0.006 DBMET00490 0.094 0.009 DBMET00492 0.082 0.014 DBMET00530 0.095 0.008 DBMET03004 0.094 0.009 DBMET03005 | DBMET00490 | |
| 0.134 | 0.068 | 0.386 | Tubulin antagonist | 0.296 0.02 DBMET00490 0.302 0.019 DBMET00492 0.134 0.068 DBMET00530 0.386 0.012 DBMET03004 0.302 0.019 DBMET03005 | DBMET03004 | |
| 0.07 | 0.005 | 0.07 | NMDA 2D receptor antagonist | 0.07 0.005 DBMET00530 | ||
| 0.093 | 0.03 | 0.093 | Selectin antagonist | 0.093 0.03 DBMET00530 | ||
| 0.088 | 0.026 | 0.326 | Beta tubulin antagonist | 0.265 0.005 DBMET00490 0.326 0.005 DBMET00492 0.088 0.026 DBMET00530 0.225 0.006 DBMET03004 0.326 0.005 DBMET03005 | DBMET03005 | |
| 0.072 | 0.012 | 0.424 | Progesterone antagonist | 0.424 0.003 DBMET00490 0.268 0.004 DBMET00492 0.072 0.012 DBMET00530 0.278 0.004 DBMET03004 0.268 0.004 DBMET03005 | DBMET00490 | |
| 0.094 | 0.035 | 0.572 | Keratolytic | 0.463 0.003 DBMET00490 0.572 0.002 DBMET00492 0.094 0.035 DBMET00530 0.419 0.003 DBMET03004 0.572 0.002 DBMET03005 | DBMET03005 | |
| 0.098 | 0.039 | 0.098 | Inducible nitric-oxide synthase inhibitor | 0.081 0.061 DBMET00490 0.098 0.039 DBMET00530 | ||
| 0.059 | 0.004 | 0.128 | Progesterone agonist | 0.128 0.003 DBMET00490 0.088 0.004 DBMET00492 0.059 0.004 DBMET00530 0.075 0.004 DBMET03004 0.088 0.004 DBMET03005 | DBMET00490 | |
| 0.086 | 0.032 | 0.202 | Glycine receptor agonist | 0.17 0.005 DBMET00490 0.202 0.004 DBMET00492 0.086 0.032 DBMET00530 0.184 0.005 DBMET03004 0.202 0.004 DBMET03005 | DBMET03005 | |
| 0.101 | 0.047 | 0.132 | NMDA receptor antagonist | 0.123 0.034 DBMET00490 0.088 0.056 DBMET00492 0.101 0.047 DBMET00530 0.132 0.03 DBMET03004 0.088 0.056 DBMET03005 | DBMET03004 | |
| 0.141 | 0.09 | 0.379 | Interferon gamma antagonist | 0.373 0.012 DBMET00490 0.379 0.012 DBMET00492 0.141 0.09 DBMET00530 0.352 0.014 DBMET03004 0.379 0.012 DBMET03005 | DBMET03005 | |
| 0.09 | 0.041 | 0.235 | Estrogen-related receptor beta agonist | 0.207 0.002 DBMET00490 0.235 0.002 DBMET00492 0.09 0.041 DBMET00530 0.187 0.003 DBMET03004 0.235 0.002 DBMET03005 | DBMET03005 | |
| 0.159 | 0.113 | 0.625 | Antimitotic | 0.276 0.051 DBMET00490 0.294 0.045 DBMET00492 0.159 0.113 DBMET00530 0.625 0.006 DBMET03004 0.294 0.045 DBMET03005 | DBMET03004 | |
| 0.054 | 0.009 | 0.054 | Purinergic P2Y2 antagonist | 0.054 0.009 DBMET00530 | ||
| 0.253 | 0.209 | 0.374 | Cyclophilin D inhibitor | 0.374 0.107 DBMET00492 0.253 0.209 DBMET00530 0.374 0.107 DBMET03005 | DBMET03005 | |
| 0.064 | 0.021 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.021 DBMET00530 | ||
| 0.062 | 0.019 | 0.062 | Heparanase inhibitor | 0.062 0.019 DBMET00530 | ||
| 0.07 | 0.03 | 0.07 | Carbonic anhydrase II inhibitor | 0.07 0.03 DBMET00530 | ||
| 0.203 | 0.165 | 0.75 | Caspase 3 stimulant | 0.477 0.024 DBMET00490 0.518 0.018 DBMET00492 0.203 0.165 DBMET00530 0.75 0.005 DBMET03004 0.518 0.018 DBMET03005 | DBMET03004 | |
| 0.051 | 0.014 | 0.066 | Farnesoid X receptor agonist | 0.045 0.018 DBMET00490 0.066 0.008 DBMET00492 0.051 0.014 DBMET00530 0.058 0.011 DBMET03004 0.066 0.008 DBMET03005 | DBMET03005 | |
| 0.042 | 0.005 | 0.042 | Dopamine D1 agonist | 0.034 0.007 DBMET00490 0.028 0.01 DBMET00492 0.042 0.005 DBMET00530 0.025 0.013 DBMET03004 0.028 0.01 DBMET03005 | ||
| 0.043 | 0.007 | 0.556 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.406 0.003 DBMET00490 0.556 0.002 DBMET00492 0.043 0.007 DBMET00530 0.425 0.003 DBMET03004 0.556 0.002 DBMET03005 | DBMET03005 | |
| 0.141 | 0.106 | 0.305 | Antipruritic | 0.305 0.013 DBMET00490 0.242 0.027 DBMET00492 0.141 0.106 DBMET00530 0.257 0.022 DBMET03004 0.242 0.027 DBMET03005 | DBMET00490 | |
| 0.095 | 0.06 | 0.095 | Breast cancer-resistant protein inhibitor | 0.095 0.06 DBMET00530 | ||
| 0.068 | 0.035 | 0.083 | NMDA 2C receptor antagonist | 0.083 0.023 DBMET00490 0.057 0.049 DBMET00492 0.068 0.035 DBMET00530 0.056 0.051 DBMET03004 0.057 0.049 DBMET03005 | DBMET00490 | |
| 0.173 | 0.142 | 0.478 | DNA damaging | 0.363 0.037 DBMET00490 0.478 0.016 DBMET00492 0.173 0.142 DBMET00530 0.346 0.042 DBMET03004 0.478 0.016 DBMET03005 | DBMET03005 | |
| 0.036 | 0.006 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.006 DBMET00530 | ||
| 0.059 | 0.031 | 0.059 | Elastase inhibitor | 0.059 0.031 DBMET00530 | ||
| 0.05 | 0.027 | 0.05 | Dopamine D2 agonist | 0.05 0.027 DBMET00530 | ||
| 0.057 | 0.034 | 0.076 | GABA receptor antagonist | 0.076 0.023 DBMET00490 0.057 0.034 DBMET00530 | DBMET00490 | |
| 0.029 | 0.007 | 0.041 | Corticosteroid-like | 0.041 0.004 DBMET00490 0.037 0.004 DBMET00492 0.029 0.007 DBMET00530 0.037 0.004 DBMET03004 0.037 0.004 DBMET03005 | DBMET00490 | |
| 0.028 | 0.006 | 0.051 | Glucocorticoid agonist | 0.051 0.004 DBMET00490 0.051 0.004 DBMET00492 0.028 0.006 DBMET00530 0.047 0.005 DBMET03004 0.051 0.004 DBMET03005 | DBMET03005 | |
| 0.029 | 0.013 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET00530 | ||
| 0.075 | 0.061 | 0.169 | Antineoplastic antibiotic | 0.082 0.056 DBMET00490 0.146 0.032 DBMET00492 0.075 0.061 DBMET00530 0.169 0.027 DBMET03004 0.146 0.032 DBMET03005 | DBMET03004 | |
| 0.015 | 0.002 | 0.324 | Transcortin receptor antagonist | 0.19 0 DBMET00490 0.324 0 DBMET00492 0.015 0.002 DBMET00530 0.162 0 DBMET03004 0.324 0 DBMET03005 | DBMET03005 | |
| 0.02 | 0.009 | 0.02 | Sodium/hydrogen exchanger inhibitor | 0.02 0.009 DBMET00530 | ||
| 0.016 | 0.004 | 0.019 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.019 0.003 DBMET00490 0.015 0.005 DBMET00492 0.016 0.004 DBMET00530 0.014 0.005 DBMET03004 0.015 0.005 DBMET03005 | DBMET00490 | |
| 0.04 | 0.033 | 0.04 | Leukocyte elastase inhibitor | 0.04 0.033 DBMET00530 | ||
| 0.048 | 0.045 | 0.048 | Carbonic anhydrase I inhibitor | 0.048 0.045 DBMET00530 | ||
| 0.047 | 0.045 | 0.068 | GABA A receptor antagonist | 0.068 0.026 DBMET00490 0.047 0.045 DBMET00530 | DBMET00490 | |
| 0.169 | 0.17 | 0.369 | DNA synthesis inhibitor | 0.284 0.049 DBMET00490 0.369 0.026 DBMET00492 0.363 0.028 DBMET03004 0.369 0.026 DBMET03005 | DBMET03005 | |
| 0.079 | 0.083 | 0.263 | Prolactin inhibitor | 0.263 0.004 DBMET00490 0.231 0.005 DBMET00492 0.21 0.007 DBMET03004 0.231 0.005 DBMET03005 | DBMET00490 | |
| 0.25 | 0.254 | 0.824 | Caspase 9 stimulant | 0.778 0.014 DBMET00490 0.81 0.01 DBMET00492 0.824 0.008 DBMET03004 0.81 0.01 DBMET03005 | DBMET03004 | |
| 0.094 | 0.099 | 0.12 | TRPA1 agonist | 0.12 0.059 DBMET00490 0.106 0.077 DBMET03004 | DBMET00490 | |
| 0.012 | 0.026 | 0.032 | Vitamin D receptor agonist | 0.02 0.007 DBMET00490 0.032 0.003 DBMET00492 0.024 0.005 DBMET03004 0.032 0.003 DBMET03005 | DBMET03005 | |
| 0.078 | 0.093 | 0.119 | ABCA1 expression enhancer | 0.116 0.034 DBMET00490 0.119 0.031 DBMET00492 0.105 0.045 DBMET03004 0.119 0.031 DBMET03005 | DBMET03005 | |
| 0.119 | 0.137 | 0.398 | Melanin inhibitor | 0.398 0.012 DBMET00490 0.272 0.025 DBMET00492 0.306 0.021 DBMET03004 0.272 0.025 DBMET03005 | DBMET00490 | |
| 0.016 | 0.035 | 0.022 | CYP24 inhibitor | 0.021 0.018 DBMET00490 0.022 0.017 DBMET00492 0.022 0.017 DBMET03004 0.022 0.017 DBMET03005 | DBMET03005 | |
| 0.085 | 0.105 | 0.192 | DNA polymerase I inhibitor | 0.174 0.037 DBMET00490 0.187 0.032 DBMET00492 0.192 0.031 DBMET03004 0.187 0.032 DBMET03005 | DBMET03004 | |
| 0.083 | 0.103 | 0.313 | Adenylate cyclase inhibitor | 0.283 0.015 DBMET00490 0.313 0.012 DBMET00492 0.285 0.015 DBMET03004 0.313 0.012 DBMET03005 | DBMET03005 | |
| 0.139 | 0.161 | 0.337 | Free radical scavenger | 0.28 0.057 DBMET00490 0.337 0.042 DBMET00492 0.269 0.061 DBMET03004 0.337 0.042 DBMET03005 | DBMET03005 | |
| 0.013 | 0.038 | 0.022 | Progesterone receptor B antagonist | 0.022 0.01 DBMET00490 | DBMET00490 | |
| 0.004 | 0.029 | 0.021 | Progesterone receptor A antagonist | 0.021 0.003 DBMET00490 0.01 0.006 DBMET00492 0.009 0.007 DBMET03004 0.01 0.006 DBMET03005 | DBMET00490 | |
| 0.024 | 0.055 | 0.067 | Estrogen-related receptor beta antagonist | 0.059 0.004 DBMET00490 0.067 0.004 DBMET00492 0.051 0.005 DBMET03004 0.067 0.004 DBMET03005 | DBMET03005 | |
| 0.034 | 0.07 | 0.041 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 DBMET00490 | DBMET00490 | |
| 0.136 | 0.178 | 0.265 | Spasmolytic | 0.193 0.125 DBMET00490 0.176 0.14 DBMET00492 0.265 0.085 DBMET03004 0.176 0.14 DBMET03005 | DBMET03004 | |
| 0.013 | 0.057 | 0.083 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.062 0.007 DBMET00490 0.049 0.008 DBMET00492 0.083 0.005 DBMET03004 0.049 0.008 DBMET03005 | DBMET03004 | |
| 0.007 | 0.053 | 0.045 | NMDA receptor phencyclidine site antagonist | 0.045 0.003 DBMET00490 0.044 0.003 DBMET00492 0.033 0.004 DBMET03004 0.044 0.003 DBMET03005 | DBMET00490 | |
| 0.009 | 0.058 | 0.022 | Telomerase stimulant | 0.02 0.008 DBMET00490 0.022 0.005 DBMET00492 0.022 0.006 DBMET03004 0.022 0.005 DBMET03005 | DBMET03005 | |
| 0.022 | 0.075 | 0.077 | Opioid kappa receptor agonist | 0.063 0.017 DBMET00490 0.049 0.025 DBMET00492 0.077 0.013 DBMET03004 0.049 0.025 DBMET03005 | DBMET03004 | |
| 0.131 | 0.184 | 0.421 | Interleukin agonist | 0.421 0.016 DBMET00490 0.292 0.052 DBMET00492 0.36 0.026 DBMET03004 0.292 0.052 DBMET03005 | DBMET00490 | |
| 0.065 | 0.119 | 0.181 | Creatine kinase inhibitor | 0.181 0.014 DBMET00490 0.129 0.035 DBMET00492 0.137 0.03 DBMET03004 0.129 0.035 DBMET03005 | DBMET00490 | |
| 0.01 | 0.065 | 0.045 | Purinergic P2X agonist | 0.045 0.011 DBMET00492 0.045 0.011 DBMET03005 | DBMET03005 | |
| 0.043 | 0.102 | 0.086 | Pregnane X receptor antagonist | 0.086 0.005 DBMET00490 0.072 0.012 DBMET00492 0.076 0.009 DBMET03004 0.072 0.012 DBMET03005 | DBMET00490 | |
| 0.089 | 0.149 | 0.345 | Protein kinase stimulant | 0.345 0.012 DBMET00490 0.227 0.033 DBMET00492 0.297 0.017 DBMET03004 0.227 0.033 DBMET03005 | DBMET00490 | |
| 0.014 | 0.075 | 0.056 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.056 0.013 DBMET00490 0.047 0.017 DBMET00492 0.037 0.023 DBMET03004 0.047 0.017 DBMET03005 | DBMET00490 | |
| 0.107 | 0.17 | 0.629 | Anesthetic general | 0.536 0.006 DBMET00490 0.629 0.004 DBMET00492 0.551 0.005 DBMET03004 0.629 0.004 DBMET03005 | DBMET03005 | |
| 0.021 | 0.085 | 0.059 | NMDA 2A receptor antagonist | 0.059 0.03 DBMET00490 | DBMET00490 | |
| 0.028 | 0.092 | 0.082 | Microtubule stabilization | 0.046 0.033 DBMET00490 0.056 0.019 DBMET00492 0.082 0.004 DBMET03004 0.056 0.019 DBMET03005 | DBMET03004 | |
| 0.021 | 0.089 | 0.101 | Dopamine D5 agonist | 0.101 0.004 DBMET00490 0.077 0.007 DBMET00492 0.062 0.011 DBMET03004 0.077 0.007 DBMET03005 | DBMET00490 | |
| 0.052 | 0.123 | 0.155 | Monophenol monooxygenase inhibitor | 0.155 0.045 DBMET00490 0.145 0.049 DBMET00492 0.129 0.056 DBMET03004 0.145 0.049 DBMET03005 | DBMET00490 | |
| 0.015 | 0.09 | 0.027 | Vitamin D receptor antagonist | 0.021 0.019 DBMET00490 0.026 0.009 DBMET00492 0.027 0.009 DBMET03004 0.026 0.009 DBMET03005 | DBMET03004 | |
| 0.004 | 0.083 | 0.03 | Ileal bile acid transport inhibitor | 0.03 0.005 DBMET00492 0.027 0.005 DBMET03004 0.03 0.005 DBMET03005 | DBMET03005 | |
| 0.043 | 0.123 | 0.078 | Analgesic, opioid | 0.078 0.05 DBMET00490 0.069 0.063 DBMET03004 | DBMET00490 | |
| 0.018 | 0.107 | 0.068 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.068 0.02 DBMET00490 0.056 0.025 DBMET00492 0.059 0.023 DBMET03004 0.056 0.025 DBMET03005 | DBMET00490 | |
| 0.018 | 0.107 | 0.047 | Hedgehog signaling activator | 0.034 0.008 DBMET00490 0.047 0.004 DBMET00492 0.043 0.004 DBMET03004 0.047 0.004 DBMET03005 | DBMET03005 | |
| 0.031 | 0.126 | 0.053 | Parathyroid hormone antagonist | 0.047 0.027 DBMET00490 0.053 0.018 DBMET00492 0.05 0.022 DBMET03004 0.053 0.018 DBMET03005 | DBMET03005 | |
| 0.035 | 0.133 | 0.052 | Alpha 1L adrenoreceptor antagonist | 0.052 0.037 DBMET00490 0.05 0.043 DBMET00492 0.05 0.043 DBMET03005 | DBMET00490 | |
| 0.017 | 0.122 | 0.054 | GABA uptake inhibitor | 0.054 0.013 DBMET00490 0.038 0.03 DBMET00492 0.038 0.03 DBMET03005 | DBMET00490 | |
| 0.126 | 0.235 | 0.602 | 5 Hydroxytryptamine release stimulant | 0.551 0.02 DBMET00490 0.602 0.014 DBMET00492 0.483 0.03 DBMET03004 0.602 0.014 DBMET03005 | DBMET03005 | |
| 0.048 | 0.16 | 0.178 | Antineoplastic alkaloid | 0.178 0.02 DBMET00490 0.178 0.02 DBMET00492 0.175 0.021 DBMET03004 0.178 0.02 DBMET03005 | DBMET03005 | |
| 0.079 | 0.193 | 0.528 | Psychostimulant | 0.528 0.009 DBMET00490 0.232 0.065 DBMET00492 0.43 0.018 DBMET03004 0.232 0.065 DBMET03005 | DBMET00490 | |
| 0.096 | 0.212 | 0.474 | P-glycoprotein inhibitor | 0.233 0.047 DBMET00490 0.368 0.019 DBMET00492 0.474 0.01 DBMET03004 0.368 0.019 DBMET03005 | DBMET03004 | |
| 0.162 | 0.281 | 0.352 | Calcium channel activator | 0.314 0.078 DBMET00490 0.352 0.049 DBMET00492 0.309 0.083 DBMET03004 0.352 0.049 DBMET03005 | DBMET03005 | |
| 0.019 | 0.141 | 0.043 | Tubulin agonist | 0.034 0.025 DBMET00492 0.043 0.012 DBMET03004 0.034 0.025 DBMET03005 | DBMET03004 | |
| 0.039 | 0.165 | 0.103 | Ornithine decarboxylase inhibitor | 0.103 0.041 DBMET00490 0.077 0.071 DBMET00492 0.078 0.07 DBMET03004 0.077 0.071 DBMET03005 | DBMET00490 | |
| 0.129 | 0.257 | 0.241 | Gastrin inhibitor | 0.241 0.09 DBMET00490 0.199 0.151 DBMET00492 0.207 0.138 DBMET03004 0.199 0.151 DBMET03005 | DBMET00490 | |
| 0.145 | 0.285 | 0.419 | Apoptosis antagonist | 0.341 0.06 DBMET00490 0.419 0.033 DBMET00492 0.336 0.063 DBMET03004 0.419 0.033 DBMET03005 | DBMET03005 | |
| 0.021 | 0.161 | 0.098 | Adenylate cyclase 1 inhibitor | 0.09 0.005 DBMET00490 0.091 0.005 DBMET00492 0.098 0.004 DBMET03004 0.091 0.005 DBMET03005 | DBMET03004 | |
| 0.032 | 0.175 | 0.169 | Acetylcholine nicotinic antagonist | 0.115 0.032 DBMET00490 0.169 0.016 DBMET00492 0.103 0.038 DBMET03004 0.169 0.016 DBMET03005 | DBMET03005 | |
| 0.088 | 0.235 | 0.225 | Hypolipemic | 0.153 0.133 DBMET00490 0.207 0.089 DBMET00492 0.225 0.08 DBMET03004 0.207 0.089 DBMET03005 | DBMET03004 | |
| 0.019 | 0.167 | 0.1 | Opioid mu receptor antagonist | 0.1 0.032 DBMET00490 0.066 0.049 DBMET00492 0.066 0.049 DBMET03005 | DBMET00490 | |
| 0.044 | 0.199 | 0.122 | Topoisomerase II inhibitor | 0.113 0.073 DBMET00490 0.122 0.065 DBMET00492 0.111 0.075 DBMET03004 0.122 0.065 DBMET03005 | DBMET03005 | |
| 0.036 | 0.193 | 0.106 | Topoisomerase I inhibitor | 0.085 0.084 DBMET00490 0.106 0.065 DBMET00492 0.096 0.074 DBMET03004 0.106 0.065 DBMET03005 | DBMET03005 | |
| 0.143 | 0.301 | 0.21 | Histamine release inhibitor | 0.21 0.19 DBMET00490 | DBMET00490 | |
| 0.051 | 0.214 | 0.194 | Acetylcholine antagonist | 0.125 0.066 DBMET00490 0.194 0.032 DBMET00492 0.141 0.056 DBMET03004 0.194 0.032 DBMET03005 | DBMET03005 | |
| 0.034 | 0.198 | 0.11 | Macrophage migration inhibitory factor inhibitor | 0.11 0.03 DBMET00490 0.098 0.036 DBMET00492 0.099 0.035 DBMET03004 0.098 0.036 DBMET03005 | DBMET00490 | |
| 0.008 | 0.174 | 0.057 | Sigma receptor antagonist | 0.057 0.03 DBMET00490 | DBMET00490 | |
| 0.013 | 0.18 | 0.07 | Potassium channel Kv1.3 blocker | 0.07 0.015 DBMET00490 0.045 0.035 DBMET00492 0.049 0.03 DBMET03004 0.045 0.035 DBMET03005 | DBMET00490 | |
| 0.051 | 0.22 | 0.198 | Cholinergic antagonist | 0.128 0.067 DBMET00490 0.198 0.032 DBMET00492 0.144 0.056 DBMET03004 0.198 0.032 DBMET03005 | DBMET03005 | |
| 0.05 | 0.225 | 0.118 | Transcription factor NF kappa B stimulant | 0.086 0.057 DBMET00490 0.11 0.031 DBMET00492 0.118 0.026 DBMET03004 0.11 0.031 DBMET03005 | DBMET03004 | |
| 0.091 | 0.267 | 0.149 | Succinate dehydrogenase inhibitor | 0.149 0.114 DBMET00490 | DBMET00490 | |
| 0.04 | 0.215 | 0.168 | Opioid kappa receptor antagonist | 0.168 0.014 DBMET00490 0.12 0.024 DBMET00492 0.12 0.024 DBMET03004 0.12 0.024 DBMET03005 | DBMET00490 | |
| 0.073 | 0.256 | 0.153 | Insulin sensitizer | 0.153 0.129 DBMET00490 | DBMET00490 | |
| 0.035 | 0.221 | 0.122 | Opioid antagonist | 0.122 0.035 DBMET00490 0.102 0.046 DBMET00492 0.098 0.049 DBMET03004 0.102 0.046 DBMET03005 | DBMET00490 | |
| 0.062 | 0.249 | 0.158 | Acetylcholine M1 receptor antagonist | 0.158 0.067 DBMET00490 0.128 0.098 DBMET03004 | DBMET00490 | |
| 0.042 | 0.233 | 0.065 | Prolactin release inhibitor | 0.065 0.035 DBMET00490 0.065 0.035 DBMET00492 0.063 0.04 DBMET03004 0.065 0.035 DBMET03005 | DBMET03005 | |
| 0.022 | 0.213 | 0.108 | Lipase inhibitor | 0.108 0.023 DBMET00490 0.073 0.051 DBMET00492 0.073 0.051 DBMET03005 | DBMET00490 | |
| 0.01 | 0.202 | 0.032 | ATP citrate lysase inhibitor | 0.032 0.021 DBMET00490 0.029 0.027 DBMET00492 0.031 0.024 DBMET03004 0.029 0.027 DBMET03005 | DBMET00490 | |
| 0.026 | 0.223 | 0.086 | Topoisomerase II alpha inhibitor | 0.086 0.048 DBMET00490 0.067 0.065 DBMET00492 0.07 0.061 DBMET03004 0.067 0.065 DBMET03005 | DBMET00490 | |
| 0.08 | 0.286 | 0.237 | Tumour necrosis factor alpha release inhibitor | 0.172 0.133 DBMET00492 0.237 0.081 DBMET03004 0.172 0.133 DBMET03005 | DBMET03004 | |
| 0.036 | 0.241 | 0.084 | GABA A receptor agonist | 0.084 0.057 DBMET00490 | DBMET00490 | |
| 0.105 | 0.312 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.147 0.05 DBMET00490 0.15 0.043 DBMET00492 0.15 0.043 DBMET03004 0.15 0.043 DBMET03005 | DBMET03005 | |
| 0.054 | 0.261 | 0.104 | Photosensitizer | 0.104 0.081 DBMET00490 0.098 0.092 DBMET03004 | DBMET00490 | |
| 0.01 | 0.218 | 0.048 | Estrogen-related receptor alpha antagonist | 0.031 0.024 DBMET00490 0.048 0.014 DBMET00492 0.048 0.014 DBMET03005 | DBMET03005 | |
| 0.008 | 0.216 | 0.046 | Dopamine D5 antagonist | 0.046 0.028 DBMET00490 | DBMET00490 | |
| 0.009 | 0.221 | 0.042 | Opioid mu receptor agonist | 0.042 0.038 DBMET00490 | DBMET00490 | |
| 0.041 | 0.256 | 0.118 | Acetylcholine muscarinic antagonist | 0.103 0.088 DBMET00490 0.118 0.069 DBMET00492 0.116 0.072 DBMET03004 0.118 0.069 DBMET03005 | DBMET03005 | |
| 0.043 | 0.267 | 0.125 | Acetylcholinesterase inhibitor | 0.125 0.074 DBMET00490 | DBMET00490 | |
| 0.051 | 0.278 | 0.187 | Aldehyde dehydrogenase inhibitor | 0.178 0.034 DBMET00490 0.121 0.07 DBMET00492 0.187 0.031 DBMET03004 0.121 0.07 DBMET03005 | DBMET03004 | |
| 0.038 | 0.271 | 0.118 | GABA receptor agonist | 0.118 0.059 DBMET00490 | DBMET00490 | |
| 0.05 | 0.284 | 0.145 | DOPA decarboxylase inhibitor | 0.145 0.024 DBMET00490 0.101 0.074 DBMET00492 0.107 0.063 DBMET03004 0.101 0.074 DBMET03005 | DBMET00490 | |
| 0.131 | 0.371 | 0.265 | 5 Hydroxytryptamine uptake stimulant | 0.265 0.067 DBMET00490 0.238 0.093 DBMET00492 0.237 0.095 DBMET03004 0.238 0.093 DBMET03005 | DBMET00490 | |
| 0.065 | 0.305 | 0.24 | Sigma receptor agonist | 0.24 0.051 DBMET00490 0.206 0.06 DBMET00492 0.197 0.063 DBMET03004 0.206 0.06 DBMET03005 | DBMET00490 | |
| 0.013 | 0.271 | 0.057 | Liver X receptor alpha agonist | 0.057 0.014 DBMET00490 0.055 0.015 DBMET00492 0.047 0.022 DBMET03004 0.055 0.015 DBMET03005 | DBMET00490 | |
| 0.018 | 0.286 | 0.068 | Dopamine D1 antagonist | 0.068 0.041 DBMET00490 | DBMET00490 | |
| 0.032 | 0.316 | 0.064 | Glutamate (mGluR6) antagonist | 0.064 0.055 DBMET00492 0.064 0.053 DBMET03004 0.064 0.055 DBMET03005 | DBMET03005 | |
| 0.023 | 0.31 | 0.113 | Expectorant | 0.113 0.056 DBMET00492 0.094 0.075 DBMET03004 0.113 0.056 DBMET03005 | DBMET03005 | |
| 0.023 | 0.316 | 0.069 | Glutamate (mGluR7) antagonist | 0.069 0.045 DBMET00490 0.067 0.049 DBMET00492 0.066 0.051 DBMET03004 0.067 0.049 DBMET03005 | DBMET00490 | |
| 0.045 | 0.345 | 0.125 | Interleukin 8 antagonist | 0.125 0.056 DBMET00490 0.104 0.088 DBMET00492 0.104 0.088 DBMET03005 | DBMET00490 | |
| 0.035 | 0.346 | 0.269 | Amylase inhibitor | 0.246 0.029 DBMET00490 0.267 0.024 DBMET00492 0.269 0.023 DBMET03004 0.267 0.024 DBMET03005 | DBMET03004 | |
| 0.038 | 0.354 | 0.119 | Toll-Like receptor 4 antagonist | 0.119 0.045 DBMET00490 0.114 0.05 DBMET00492 0.116 0.048 DBMET03004 0.114 0.05 DBMET03005 | DBMET00490 | |
| 0.027 | 0.344 | 0.095 | Mucolytic | 0.093 0.088 DBMET00492 0.095 0.085 DBMET03004 0.093 0.088 DBMET03005 | DBMET03004 | |
| 0.026 | 0.35 | 0.165 | Cystathionine beta-synthase inhibitor | 0.165 0.034 DBMET00490 0.114 0.062 DBMET00492 0.133 0.049 DBMET03004 0.114 0.062 DBMET03005 | DBMET00490 | |
| 0.044 | 0.369 | 0.126 | Peroxidase inhibitor | 0.126 0.094 DBMET00490 | DBMET00490 | |
| 0.062 | 0.389 | 0.262 | Cardiotonic | 0.174 0.146 DBMET00490 0.262 0.074 DBMET00492 0.262 0.074 DBMET03005 | DBMET03005 | |
| 0.038 | 0.374 | 0.128 | Hedgehog signaling inhibitor | 0.118 0.041 DBMET00490 0.128 0.034 DBMET00492 0.099 0.066 DBMET03004 0.128 0.034 DBMET03005 | DBMET03005 | |
| 0.03 | 0.368 | 0.181 | Neurotrophic factor | 0.181 0.037 DBMET00490 0.144 0.065 DBMET00492 0.159 0.051 DBMET03004 0.144 0.065 DBMET03005 | DBMET00490 | |
| 0.079 | 0.418 | 0.268 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.268 0.035 DBMET00490 0.24 0.047 DBMET00492 0.262 0.037 DBMET03004 0.24 0.047 DBMET03005 | DBMET00490 | |
| 0.014 | 0.355 | 0.118 | Anesthetic local | 0.118 0.068 DBMET00490 | DBMET00490 | |
| 0.101 | 0.448 | 0.255 | Tyrosine 3 hydroxylase inhibitor | 0.255 0.063 DBMET00490 0.187 0.161 DBMET00492 0.192 0.151 DBMET03004 0.187 0.161 DBMET03005 | DBMET00490 | |
| 0.073 | 0.424 | 0.22 | Growth factor agonist | 0.22 0.047 DBMET00490 0.202 0.06 DBMET00492 0.174 0.095 DBMET03004 0.202 0.06 DBMET03005 | DBMET00490 | |
| 0.014 | 0.372 | 0.086 | Adrenaline uptake inhibitor | 0.086 0.024 DBMET00492 0.086 0.024 DBMET03005 | DBMET03005 | |
| 0.009 | 0.369 | 0.053 | Alcohol oxidase inhibitor | 0.053 0.042 DBMET00490 | DBMET00490 | |
| 0.036 | 0.397 | 0.137 | Amyloid beta aggregation inhibitor | 0.137 0.118 DBMET00490 | DBMET00490 | |
| 0.078 | 0.446 | 0.191 | Immunomodulator | 0.191 0.175 DBMET03004 | DBMET03004 | |
| 0.036 | 0.425 | 0.13 | Cyclooxygenase 3 inhibitor | 0.128 0.069 DBMET00490 0.13 0.066 DBMET03004 | DBMET03004 | |
| 0.028 | 0.421 | 0.097 | Thioredoxin inhibitor | 0.097 0.052 DBMET03004 | DBMET03004 | |
| 0.056 | 0.454 | 0.3 | Transcription factor STAT3 inhibitor | 0.281 0.063 DBMET00490 0.3 0.053 DBMET00492 0.263 0.074 DBMET03004 0.3 0.053 DBMET03005 | DBMET03005 | |
| 0.022 | 0.434 | 0.088 | Alpha 2c adrenoreceptor antagonist | 0.088 0.077 DBMET00492 0.088 0.077 DBMET03005 | DBMET03005 | |
| 0.043 | 0.456 | 0.083 | Glutamate release inhibitor | 0.083 0.081 DBMET00490 | DBMET00490 | |
| 0.039 | 0.474 | 0.201 | Vasodilator | 0.201 0.104 DBMET00492 0.201 0.104 DBMET03005 | DBMET03005 | |
| 0.014 | 0.456 | 0.054 | Botulinum neurotoxin type A inhibitor | 0.054 0.048 DBMET03004 | DBMET03004 | |
| 0.008 | 0.454 | 0.061 | Dopamine uptake inhibitor | 0.061 0.037 DBMET00492 0.061 0.037 DBMET03005 | DBMET03005 | |
| 0.023 | 0.474 | 0.14 | Pyruvate kinase inhibitor | 0.14 0.125 DBMET00490 | DBMET00490 | |
| 0.012 | 0.47 | 0.059 | Nitric oxide donor | 0.059 0.05 DBMET03004 | DBMET03004 | |
| 0.005 | 0.467 | 0.062 | 5 Hydroxytryptamine uptake inhibitor | 0.062 0.045 DBMET00492 0.062 0.045 DBMET03005 | DBMET03005 | |
| 0.006 | 0.471 | 0.064 | Opioid delta receptor antagonist | 0.064 0.044 DBMET00490 | DBMET00490 | |
| 0.016 | 0.482 | 0.084 | Bronchodilator | 0.084 0.081 DBMET00492 0.084 0.081 DBMET03005 | DBMET03005 | |
| 0.015 | 0.501 | 0.203 | M18 aspartyl aminopeptidase inhibitor | 0.127 0.065 DBMET00490 0.203 0.033 DBMET00492 0.104 0.087 DBMET03004 0.203 0.033 DBMET03005 | DBMET03005 | |
| 0.017 | 0.533 | 0.15 | AMP-activated protein kinase stimulant | 0.091 0.083 DBMET00490 0.15 0.028 DBMET00492 0.113 0.055 DBMET03004 0.15 0.028 DBMET03005 | DBMET03005 | |
| 0.061 | 0.587 | 0.263 | GABA C receptor rho-3 antagonist | 0.263 0.143 DBMET00490 | DBMET00490 | |
| 0.012 | 0.545 | 0.08 | Alpha 2 adrenoreceptor antagonist | 0.08 0.067 DBMET00492 0.08 0.067 DBMET03005 | DBMET03005 | |
| 0.097 | 0.638 | 0.355 | Calcium channel L-type activator | 0.355 0.113 DBMET00490 0.235 0.222 DBMET00492 0.297 0.16 DBMET03004 0.235 0.222 DBMET03005 | DBMET00490 | |
| 0.05 | 0.604 | 0.298 | Vasodilator, peripheral | 0.245 0.131 DBMET00490 0.298 0.098 DBMET00492 0.293 0.1 DBMET03004 0.298 0.098 DBMET03005 | DBMET03005 | |
| 0.026 | 0.597 | 0.22 | Interleukin 6 antagonist | 0.17 0.064 DBMET00490 0.22 0.031 DBMET00492 0.187 0.049 DBMET03004 0.22 0.031 DBMET03005 | DBMET03005 | |
| 0.036 | 0.613 | 0.31 | Transcription factor STAT inhibitor | 0.275 0.071 DBMET00490 0.283 0.066 DBMET00492 0.31 0.05 DBMET03004 0.283 0.066 DBMET03005 | DBMET03004 | |
| 0.019 | 0.615 | 0.077 | MAP kinase kinase 7 inhibitor | 0.077 0.056 DBMET00492 0.077 0.056 DBMET03005 | DBMET03005 | |
| 0.009 | 0.641 | 0.062 | Acetyl-CoA transferase 2 inhibitor | 0.062 0.027 DBMET00492 0.06 0.03 DBMET03004 0.062 0.027 DBMET03005 | DBMET03005 | |
| 0.021 | 0.654 | 0.102 | Lanosterol 14 alpha demethylase inhibitor | 0.102 0.053 DBMET00492 0.087 0.077 DBMET03004 0.102 0.053 DBMET03005 | DBMET03005 | |
| 0.022 | 0.665 | 0.161 | Cyclic AMP phosphodiesterase inhibitor | 0.161 0.134 DBMET00490 0.156 0.143 DBMET00492 0.155 0.144 DBMET03004 0.156 0.143 DBMET03005 | DBMET00490 | |
| 0.043 | 0.716 | 0.253 | 5 Hydroxytryptamine release inhibitor | 0.253 0.224 DBMET00490 | DBMET00490 | |
| 0.028 | 0.726 | 0.288 | Hypoglycemic | 0.288 0.057 DBMET00492 0.288 0.057 DBMET03005 | DBMET03005 | |
| 0.037 | 0.754 | 0.134 | MAP kinase kinase 4 inhibitor | 0.134 0.102 DBMET00492 0.134 0.102 DBMET03005 | DBMET03005 | |
| 0.009 | 0.759 | 0.06 | Transcription factor AP-1 inhibitor | 0.06 0.045 DBMET00492 0.06 0.045 DBMET03005 | DBMET03005 | |
| 0.008 | 0.815 | 0.047 | Glucose-6-phosphate translocase inhibitor | 0.047 0.045 DBMET00492 0.047 0.045 DBMET03005 | DBMET03005 | |
| 0.045 | 0.943 | 0.183 | Peptidyltransferase inhibitor | 0.183 0.123 DBMET00492 0.183 0.123 DBMET03005 | DBMET03005 | |
| 0.002 | 0.95 | 0.018 | Adenosine A3 receptor agonist | 0.018 0.011 DBMET00492 0.018 0.011 DBMET03005 | DBMET03005 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |